• Elevacity, SHRV’s new health-and-wellness division, features numerous products, including skincare for men and women and a proprietary blend of smart coffee
• Global direct sales market is expected to reach $163.1 billion by 2020 with a CAGR of 4.9 percent
• SHRV is pursuing international expansion, entering a joint venture agreement to market its Elepreneur brand and products in Asia

Sharing Services, Inc. (OTC: SHRV) has announced a $2.4 million record in gross sales for the month of March, doubling its total sales in February (http://ibn.fm/L9HlE). The revenue was driven by the execution of its go-to-market strategy and the debut of its Elevacity health-and-wellness division.

Elevacity focuses on life changing wellness products integrated with a rewards program. Products include the Timeless line of skincare for men and women, vitamin patches that are designed to generate energy and anti-aging Elier Mud.

SHRV is a Plano, Texas-based diversified holding company that owns, operates or controls a variety of companies engaged in direct selling through independent sales representatives. It also offers services in energy, technology and insurance markets. The company is taking steps to expand direct selling internationally. Earlier this year, it finalized a joint venture with Hong Kong-based Health Wealth & Happiness Ltd. (“HWH”) to expand the Elepreneur Brand and sell its products throughout Asia (http://ibn.fm/PJYDF).

Worldwide, direct selling is projected to reach retail sales of $163.1 billion by 2020, with a CAGR of 4.9 percent, according to an article by FinancialBuzz.com, quoting from a report by Euromonitor International Ltd. (http://ibn.fm/g5n51).

In a recent news release, Robert Oblon, chairman of SHRV, said, “We have exceeded our goals as we continue our record-breaking pace within direct selling, but our best-in-class products and services are proving the concept on our very unique Blue Ocean Strategy.” That is defined as a method of selling in an uncontested market space employing a number of other strategies to gain success.

For more information, visit the company’s website at www.SharingServicesInc.com

• CEO and co-founder William Waldrop attended several events, detailed his company’s operations and growth plans in the context of a rapidly expanding cannabis market with its associated auxiliary services
• Special Cannabis Investing Event was included in The MoneyShow Las Vegas schedule, with prominent industry speakers in attendance
• Topics of discussion revolved around medical and recreational marijuana, ancillary services, investment opportunities, leading companies and more

The rapid expansion of the cannabis industry over the last couple of years took center stage at The MoneyShow Las Vegas on May 14-16, with multiple workshops, meetings and panels organized as part of a special Cannabis Investing Event. With the cannabis industry rapidly growing, it is garnering the attention and interest of many investors. Prominent industry speakers from multiple cannabis-related sectors attended the event, taking the opportunity to tackle a wide range of relevant topics and important trends that cannabis investors need to know. The list of speakers included William Waldrop, CEO of EVIO, Inc. (OTCQB: EVIO), a leading provider of cannabis analytical testing and research services for the regulated industry (http://ibn.fm/6yclN).

Waldrop had multiple speaking engagements during the Las Vegas event, starting with a special session tackling cannabis testing, organized on Tuesday, May 15. The speaking session, called “Intro to EVIO and Cannabis Testing,” (http://ibn.fm/0hSKo) focused on the growing need and demand for reliable cannabis testing in the context of a rapidly expanding market in which quality control assurances are paramount, as the use of cannabis and cannabinoids, especially for medical purposes, continues to grow. Talks also touched on the latest regulations and standards in the industry, but mostly focused on EVIO and its EVIO Labs division, which provides coast-to-coast accredited cannabis testing services via 11 testing facilities.

An established national leader in cannabis testing and verification, along with detection of possible harmful components that can compromise product quality and consumer health, EVIO also provides consulting services to cannabis producers and growers in an effort to help them meet quality goals, optimize their growing process and achieve regulatory compliance.

The EVIO CEO was also one of the guest speakers at the Cannabis Investing Event’s panel on “Recreational Marijuana: A Major Opportunity for Investors,” on May 15 (http://ibn.fm/tq53Q). Speakers at the panel discussed the significant opportunities associated with the recreational marijuana market, both for investors and for companies already active in the niche, from Canada (set to legalize recreational use this summer) to California (which voted to legalize the drug in a statewide poll in November 2016). Canada and California are currently the largest cannabis markets in the world, a fact that came into focus at The MoneyShow Las Vegas, with special sessions dedicated to the introduction of cannabis experts capitalizing on these two markets.

Another major speaking engagement for EVIO was “Taking the Guesswork out of Cannabis,” organized on Wednesday, May 16 (http://ibn.fm/cfiuL). The main topic of discussion during this workshop was how companies can “profit from the plant without touching the plant,” and it provided an extensive overview of the cannabis market’s ancillary services sector and the alternative investment opportunities that it presents. Discussion topics included the need for testing labs and how these facilities serve as gatekeepers, monitoring the safety and quality of cannabis before it is marketed to consumers. Auxiliary services include, among others, laboratory testing, consulting, compliance, extraction equipment, packaging, software development, staffing, security, media and publishing.

Founded in 1981, MoneyShow’s annual live and online events tackling major investment and trading topics have attracted tens of thousands of investors, advisors, traders and market experts. MoneyShow began covering the legal cannabis industry in February 2015, with this year’s event focusing on several key themes for 2018, such as biotech and medical marijuana, the United States marijuana revolution and the companies at its forefront, investing in cannabis and much more.

For EVIO, the MoneyShow participation follows on the heels of its expansion into the international market with its recent 100 percent acquisition of Leaf Detective, LLC in California and it 50 percent acquisition of Keystone Labs Inc. in Canada. These strategic acquisitions position EVIO for sustained growth in the world’s largest cannabis markets, and the company is on track to have 18 of its state-of-the-art testing facilities by year-end 2018.

For more information, visit the company’s website at www.EVIOLabs.com

• High-pressure lab equipment maker reports ninth consecutive quarter of revenue growth (Y/Y)
• About 92 percent of debenture debt converted to preferred stock, with aim of uplisting to national stock exchange
• Patented technologies continue to drive optimism for company’s products to enhance and improve scientific research

Pressure BioSciences, Inc. (OTCQB: PBIO), the maker of a patented and powerful line of pressure-based scientific laboratory tools, celebrated corporate gains on May 15 with the announcement of first quarter revenue growth and debenture conversion.

The first quarter of 2018 was the ninth consecutive quarter in which the company reported an increase in products and services revenue on a year-over-year basis and the second time during the past year in which the company reported total quarterly revenue of more than $600,000. Sales of the company’s instruments established a new quarterly record, and sales of the instruments’ consumable elements increased by 18 percent following on a 21 percent revenue increase for the final quarter of 2017.

In addition to the revenue achievements, the company reported that, operationally, it was advancing in its relationships with clients as a new cadre of sales directors began working in their assigned geographical areas.

“Perhaps most exciting was the news released just today – that a majority of our 2015/2016 Convertible Debenture Holders have agreed to convert approximately $6.39M of Debentures into Series AA Preferred Stock,” CEO and President Richard T. Schumacher stated in a news release. “This represents about 92% of all 2015/2016 Debenture debt on our balance sheet as of March 31, 2018.”

Schumacher reported that discussions are ongoing with other debt holders about converting their notes into equity, which would give the company a “materially stronger” balance sheet at the end of the second quarter.

“We believe that such a change would have a significant, positive effect on the growth of PBI going forward, and would materially enhance our stated objective of up-listing to a national exchange (NASDAQ, NYSE/Amex) later in 2018,” Schumacher stated.

Pressure BioSciences is focused on the development and sale of instruments and consumables that use high pressures to break open cells in a more efficient, beneficial and reproducible way than today’s standard methods, such as mechanically “beating up” cells amid research aimed at developing medicinal and therapeutic products. The high-pressure products can also be used in counter-terrorism and criminal forensics applications.

The company’s products employ the properties of both constant (static) and alternating (cycling) hydrostatic pressure. The company’s patented pressure cycling technology (PCT) uses alternating cycles between ambient and ultra-high pressures to control biomolecular interactions in a reproducible way that allows for standards compliance reporting to government agencies.

“Because it is so powerful, unique, and enabling, Pressure Cycling Technology (PCT) could play a crucial role for the new generation of discoveries yet to be made. By carefully controlling the breakage of a cell in order to safely and reproducibly release the proteins, lipids, DNA and RNA contained inside the cell, the molecules released have been reported by numerous authors to be of greater quality, which importantly could result in newer, faster, and better discoveries,” Schumacher said in a January interview (http://ibn.fm/7Jjrp).

One of Pressure BioSciences’ newest clients is a company using a patented technology platform acquired as part of Pressure BioSciences’ recent purchase of Colorado-based therapeutic drug developer BaroFold, Inc., a company Schumacher described as available at a bargain price after it “ran into some (operational) problems” that he believes Pressure BioSciences can overcome at relatively low cost. The acquisition gave Pressure BioSciences eight new pressure-related patents and extended the potential for the company’s existing patents.

This newly acquired technology platform, called PreEMT, also holds the promise that a protein drug maker might someday decide to use the company’s PreEMT technology platform in the routine manufacture of its drug to make a higher quality therapeutic, which in turn could result in the drug maker paying a hefty royalty license fee to PBI – perhaps in the millions of dollars per year. “The BaroFold technology platform offers a cutting-edge method to increase the quality and reduce the cost of manufacturing protein drugs. We’ve opened up a whole new and exciting business unit for PBI and our shareholders, one that offers the potential to generate millions of dollars in revenue, per year”, Schumacher said earlier this year.

The company also announced a co-marketing and distribution agreement with ISS, Inc., for high-pressure optical cell systems used in some lab processes. The two-year agreement will include replacing the manual pressure generator used in ISS’s product with Pressure BioSciences’ computer-controlled instruments.

For more information, visit the company’s website at www.PressureBioSciences.com

• Solvent mixing process extracts bitumen without creating greenhouse gases, wastes
• Petroteq to begin commercial production this year as it ramps up output
• Company’s Utah lease believed to hold 86 million barrels of extractable oil

The commercial exploration and extraction of petroleum distillates to feed the world’s fuel needs has been a vital industry for some 160 years, and it shows no sign of abating “anytime soon,” according to Raymond Gerald Bailey, president of Petroteq Energy Inc. (TSX.V: PQE) (OTC: PQEFF), the developer of patented technologies that facilitate the environmentally friendly extraction and processing of oil.

Petroteq’s proprietary extraction process uses solvents to produce zero greenhouse gas, zero waste and no high temperatures, unlike existing processes in use by other companies that leave vast tailing ponds that take years for land reclamation, according to the company’s website (www.Petroteq.energy). As world governments drive demand for an increase in electric vehicle production to combat global pollution, Petroteq’s concern for the ecosystem creates a rollout-ready solution.

Last year, researchers at the Freedonia Group predicted that the North American consumer market for asphalt bitumen would continue to expand in conjunction with road maintenance needs throughout the United States and neighboring countries through 2021 (http://ibn.fm/hZ2j9). Petroteq has been testing its extraction process to boost North American production on a bituminous mineral lease that covers more than 3,000 acres in Utah since 2015. The U.S. Department of Energy estimates that there are more than a trillion barrels of oil locked in desert sand and shale formation in the state and neighboring Colorado and Wyoming.

Petroteq believes that its lease contains an oil sands resource base of approximately 86 million barrels of oil equivalent that can be extracted. The company recently expanded the production capacity of its Asphalt Ridge plant in Utah by 400 percent, from 250 to 1,000 barrels per day, and it has set a goal of 5,000 barrels of oil per day by next year as it ramps up commercial production. Utah contains approximately 55 percent of the total oil sands deposits in America, and the company plans to begin construction of a new plant in the state next year on its Temple Mountain lease.

The company’s patented technology utilizes a process of mixing oil sands in a bin with a solvent solution before transporting the mixture to a mill. At the mill, the ore mixture is crushed to make the oil disperse better in the solvent. It is then shaken before the fluid is then pumped out to where the mixture’s solids can be removed. The remaining fluid is then pumped out to be distilled through a heat process that separates the solvent from the oil. The oil is then stored in tanks while the evaporated solvent is reclaimed for use once again in the mixture bin.

The company is developing a proprietary PetroBLOQ supply chain management technology based on the blockchain platform, through a collaboration with First Bitcoin Capital Corp., to improve record keeping and the security of its transactional processes. While PetroBLOQ is being designed to improve cost efficiency and time management for the company, it will ultimately be usable for expansion projects or other smart contract clients in the oil and gas industry.

Petroteq also has a joint venture with Recruiter.com and Oilprice.com to provide job placement and industry career services for the increasingly specialized energy sector, and the company has a minority stake in an exploration and production project for heavy oil reserves in southwest Texas through Accord GR Energy Inc.

For more information, visit the company’s website at www.Petroteq.energy

• Joint venture with MCOA establishing hemp farms in U.S. and Canada
• CBD hemp propagation phase and the development of outdoor-indoor facilities to maintain year-round cycle
• Oregon farm covers 109 acres; greenhouses will add 19,296 square feet of indoor production space

Global Hemp Group, Inc. (CSE: GHG) (FRANKFURT: GHG) (OTC: GBHPF), a company dedicated to building a portfolio of hemp-friendly businesses intent on producing the ancient crop renowned for its use in paper, textiles, rope and building materials, is celebrating the recent property acquisition and the advancement of its farming operations in Scio, Oregon.

“Garden operations are well underway at the farm. The initial nursery and propagation rooms for clones has recently been expanded to an additional attached greenhouse as the team continues to produce clones for planting in the current season,” the company stated in a May 15 news release (http://ibn.fm/bcQ2w). “In order to maximize planting density, an additional 20,000 high yielding CBD hemp clones are being purchased and will be delivered before the end of May to meet the targeted planting schedule of early June.”

Global Hemp Group was founded in 2014 with Canadian headquarters in Vancouver, British Columbia, and additional base operations in Montreal and Los Angeles. Its hemp cultivation efforts are initially focused on the production of high quality sustainable raw materials and non-psychotropic cannabidiol (CBD) oil, as well as other cannabinoids, with no intoxicating effects. Global Hemp Group’s collaboration with other companies is an integral part of its aim to eventually implement its Hemp Agro-Industrial Zone (HAIZ) concept, under which it will cultivate hemp for additional value-added industrial products as it explores the profit potential of construction materials and other uses.

The Oregon farming project is taking place with the assistance of joint venture partner Marijuana Company of America, Inc. (OTC: MCOA) and involves planting of approximately 30,000 clones on 35 acres. Five additional greenhouses have been purchased in order to increase the project’s productivity through perpetual productivity indoors when the outdoor growing season wanes. Two of the greenhouses are being installed, and the remainder will begin installation before the end of May, adding 19,296 square feet of active indoor space for cultivation.

“This dual strategy will optimize revenue generation throughout the year to minimize the impact of single crop harvesting in October when most other hemp CBD farms harvest and typically drive prices down,” the news release states.

The Oregon field and greenhouse work join the partners’ traditional dense field cultivation project in New Brunswick, Canada. The lower yielding CBD cultivars there have been reintroduced to the region for the first time in 20 years as part of the companies’ plan to resume large-scale commercial hemp production and to establish a nearby processing facility. Last year’s initial cultivation research in New Brunswick will aid the company in determining the optimal yield per acre for both the United States and Canada sites.

Canada is working steadily toward fulfilling a government mandate legalizing all uses of the cannabis plant before the end of the year, which will also include cannabinoid extraction from the flowers and leaves of the hemp plant. Cultivation of the industrial hemp plant in the U.S. has some form of legal recognition under a majority of the states’ legislatures. Earlier this year, there was welcomed news that the United States Congress is considering an updated Hemp Farming Act that would remove the non-psychoactive plant from the Drug Enforcement Administration’s listing of controlled substances (http://ibn.fm/YB35K).

For more information, visit the company’s website at www.GlobalHempGroup.com

• Net revenues in Q1 2018 increased 18 percent over Q1 2017 to $16 million
• Total transaction dollars processed globally during Q1 2018 increased 51 percent to $839 million
• Named as one of the fastest-growing companies in North America on Deloitte’s 2017 Technology Fast 500
• Launched Netevia, a future-ready, multi-channel payments platform, to provide same business-day settlement and funding for merchants

Net Element, Inc. (NASDAQ: NETE), a global technology and value-added solutions group that supports electronic payments acceptance in a multi-channel environment, continues to reach competitive milestones across all segments of its core business, according to the company’s May 15 conference call with investors (http://ibn.fm/urMo6). Financial results for the first quarter ended March 31, 2018, show that Net Element continues to experience organic growth, with net revenues increasing to $16 million, an increase of 18 percent over the same period last year.

“We are pleased to have made a strong start to the year, becoming more competitive for our sales partners and merchants while continuing to deliver growth,” Oleg Firer, CEO of Net Element, said during the call. “We expect to continue to improve growth across all segments during the year.”

First quarter highlights of 2018 are many, including the February 7 launch of Netevia, a proprietary, future-ready multi-channel payments platform. Connecting and simplifying payments across sales channels through a single integration point, Netevia delivers end-to-end payment processing through easy-to-use APIs. This model complements Net Element’s ability to perform in a multi-channel environment, including point-of-sale (POS), e-commerce and mobile devices. Other value-added services offered through the Netevia platform include fast, easy merchant account opening and integration, payment conversion optimization, over 150 risk-monitoring filters and highly competitive pricing for payment acceptance services.

Looking forward, Netevia will form part of the recently announced technology solution to connect with merchants and customers via an efficient blockchain technology enabled transaction processing ecosystem with an ability to build value-added services for platform users (http://ibn.fm/CW2ea). Net Element is a member of the prestigious Enterprise Ethereum Alliance (“EEA”), the world’s largest open-source blockchain initiative, with over 250 member companies. Net Element’s entrance into the EEA is complementary to many of the company’s initiatives, including its decentralized blockchain technology solution that will permit endless value-added services.

“Net Element is focused on delivering value-added solutions for our community as we develop decentralized blockchain solutions to connect merchants and consumers,” Firer said in announcing the company’s entry into the EEA. “Alongside leading global enterprises, such as Microsoft, Intel, JPMorgan, Samsung, ING, MasterCard, Thomson Reuters, Cisco Systems, and others, we have partnered with EEA to establish clear roadmap, robust governance model, and useful Ethereum resources.”

Net Element’s North American Transaction Solutions segment continues to generate the lion’s share of the company’s revenues, increasing 27 percent over the same period of the prior year to $14 million. The International Transaction Solutions segment brought in $2 million following the consolidation of the Online and Mobile Solutions segments during 2017.

“As previously stated in our recent press releases and our filings, the Company is in the best financial position in its history and poised for continued growth,” Firer informed investors during the conference call. “We are pleased to present the progress we have made during the first quarter and are working diligently to increase shareholder value by growing revenues, reducing expenses and creating proprietary payment services technology and services that benefit our merchants and their customers.”

For more information, visit the company’s website at www.NetElement.com

• ETST now begins 2017 fiscal year audit, which is required along with the approved Form 10 to uplist to the OTCQB
• Biotech company is focused on developing medical devices for the pharmaceutical and nutraceutical fields and marketing high-grade hemp cannabidiol (CBD)
• In a news release, Dr. Michel Aube, CEO and chief science officer of ETST, says that, following completion of audit, he sees investor confidence growing and ETST seeking to secure its first big round of financing

Earth Science Tech, Inc. (OTC: ETST) has announced completion of its audit for FY2015 and FY2016 and submitted its Form 10 to become fully reporting (http://ibn.fm/aHILK). ETST is now commencing its audit for FY2017. That audit and the approved Form 10 submission are required for an uplisting to the OTCQB Venture Market.

In a news release, Dr. Aube said, “We are in touch with institutional and private investors that were waiting for ETST to become a fully reporting company before investing the necessary amount to commercialize our projects. We can now resume our discussions with them.” He also said that transparency is a key tool in the growth of ETST’s business and gaining investor confidence.

Florida-based ETST is an innovative biotech company marketing a repositioned line of High Grade Full Spectrum cannabidiol.  Focused on manufacturing, marketing and distributing its cannabinoid products to the pharmaceutical and nutraceutical markets, it also conducts R&D on low cost, non-invasive medical devices.

Nickolas Tabraue, ETST director and president, added, “This is a major achievement for ETST, and becoming a fully reporting OTCQB company is going to open many opportunities while boosting investor confidence.”

ETST holds four wholly owned subsidiaries. One is Earth Science Pharmaceutical, which develops medical diagnostic tools and vaccines. Cannabis Therapeutics is an emerging biotechnology company. KannaBidioiD is focused on manufacturing and distributing in the recreational space. Earth Science Foundation, Inc. is in the process of becoming a non-profit, and it will accept grants and donations to conduct further studies.

For more information, visit the company’s website at www.EarthScienceTech.com

• QuadSight™ technology improves night vision
• Eyes-On™ technology provides unique stereo vision advanced driver assistance
• Eye-Net™ technology offers real-time pre-collision alerts to vehicles and pedestrians

Seeing is believing, it’s been said, but we know that our eyes can’t always be trusted. For centuries, we hypothesized a geocentric universe, for example, based on seeing the sun ‘rising’ in the east and ‘setting’ in the west. Now we know that it’s only the moon that goes around the Earth. In our planetary system, the sun takes center stage. In more earthly matters, the same is true; we see things that are not there and fail to notice things that are, which is a huge problem if you’re operating a vehicle. So, Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX) is out to help drivers see straight. The innovative Israeli company has developed technology that ‘sees’ a wider spectrum of frequencies than the human eye. The improved vision can only lead to safer driving.

Driving at night can be a challenge. To see objects, our eyes must detect the light reflected from them. The absence of daylight at night means reduced vision, because the intensity of light has decreased. But this doesn’t stop mosquitoes from biting at night, for they can ‘see’ the infrared ‘light’ reflected from our bodies and find us in the dark. Mosquitoes can detect frequencies in the electromagnetic spectrum that the human eye cannot, frequencies that resemble ‘heat’ much more than they do ‘light’. Being able to detect the heat radiation emitted by warm-blooded animals enhances the mosquito’s night vision. Infrared vision technology, like that being developed by FRSX, does the same. It improves vision by expanding the spectral range of detected radiation.

FRSX’s QuadSight technology is automotive vision, perfected. It sets a new bar for autonomous vehicle vision by achieving near 100 percent obstacle detection with near zero false alerts. The QuadSight System provides accurate obstacle detection under all weather and lighting conditions and comprises two sets of stereoscopic infrared and visible-light cameras, above the windshield, in the pattern: Infrared-Visible Light-Visible Light-Infrared on the front of the vehicle. QuadSight will detect obstacles, regardless of shape, form or material. Its sensors fuse the visible light and infrared radiation into a seamless 24/7 vision, while advanced algorithms perform 3D image analysis for accurate depth and obstacle detection.

FRSX has also developed Eye-Net, accident prevention technology that provides real-time pre-collision alerts to vehicles and pedestrians. The proprietary system uses a smartphone app that links to cloud-based servers operating on existing cellular networks, eliminating the need for additional designated hardware. Eye-Net goes beyond FRSX’s basic detection technology. It adds a complementary layer of protection to advanced driver assistance systems and extends this protection to road users who are not in direct line of sight. On March 28, 2018, Foresight announced that it had completed a successful feasibility study of its Eye-Net accident prevention solution involving 120 users of Android and iOS cell phones located across Israel.

In early May 2018, FRSX announced that it had signed a merger agreement with Tamda Ltd. (TASE: TMDA) and its controlling shareholder, Ipax Issues Ltd. According to the agreement, Foresight will spin off its activities dedicated to the development of its Eye-Net accident prevention system into its wholly owned subsidiary, which will then merge with Tamda (http://ibn.fm/j4u4m).

FRSX also offers Eyes-On, a unique stereo vision Advanced Driver Assistance System (ADAS) that employs advanced algorithms for accurate depth analysis and obstacle detection. The Eyes-On system will detect all potential obstacles, including vehicles, cyclists, pedestrians, animals and inanimate objects, at a high degree of accuracy.

For more information, visit the company’s website at www.ForesightAuto.com

• Targeting combined cannabis market of 60 million adults
• Constructing cannabis grow facilities in California and Canada
• Diversified operations with cross-sector, cross-border footprints

The tide of cannabis legalization in North America is rising steadily to a flood, and nowhere is this more apparent than in the world’s two largest markets, California and Canada. The former was the first U.S. state to legalize (in 1996) medical marijuana, and, since January 1, 2018, has legally permitted marijuana for adult recreational use. In Canada, liberalization has followed a similar timeline. The Marihuana Medical Access Regulations (MMAR) were enacted in July 2001. They were superseded by the Marihuana for Medical Purposes Regulations (MMPR) in July 2013, which were then replaced in August 2016 by the current regime, the Access to Cannabis for Medical Purposes Regulations (ACMPR). Adult recreational use depends on the enactment of Bill C-45 (the Cannabis Act) by the Canadian House of Commons, which is expected before the end of summer. Together, these two markets comprise a colossal adult consumer base of around 60 million, divided equally at about 30 million each. It’s a base that Sunniva Inc. (CSE: SNN) (OTCQX: SNNVF) is targeting. The company currently has separate growing facilities under construction in these two markets, including the California Campus at Cathedral City, California, and the Canada Campus at Okanagan Falls, British Columbia.

With an economy that would place it at number six in a global GDP listing, California is now the world’s premier cannabis market. It’s a market that looks set to reach almost $4 billion in 2018. In addition, forecasts in Canada call for a market value of $1.7 billion by 2020.

Phase one of the California Campus, a 325,000 sq. ft. greenhouse in Cathedral City, is well underway. Sunniva expects the facility, with an estimated capacity of 60,000 kg annually at full production, including trim, will become operational in Q3 2018. Trim consists of leaves and other parts of the plant removed during pruning. A second phase, which will add another 164,000 sq. ft. and yield an expected 40,000 kg per year, is on the drawing board. Sunniva also has a state licensed extraction facility in operation capable of processing 500 lbs. (227 kg) of biomass a day, or 125,000 lbs. (56,700 kg) per year, into high margin drug delivery formats such as vape oil, capsules, tinctures and sprays. Sunniva’s U.S. subsidiaries now hold eight 10,000 sq. ft. cultivation licenses, one 22,000 sq. ft. cultivation license, one 22,000 sq. ft. nursery license, one 10,000 sq. ft. nursery license and two manufacturing licenses (http://ibn.fm/BNWje).

Additionally, Sunniva provides private label vaporizer devices to over 80 brands in California. At present, the company supplies only the hardware and packaging for these devices. However, it plans to fill the vaporizers with cannabis from its own facilities as soon as that is forthcoming, adding value to the products supplied to its white label clients.

Earlier in May 2018, Sunniva announced it had selected the 126-acre Okanagan Falls, British Columbia site at which to build its Canada Campus (http://ibn.fm/pA2GT). The 700,000 sq. ft. facility will have an expected output capacity of 100,000 kg annually, and it is anticipated to become operational in Q1 2019. About 75 percent of output will be pre-sold on a wholesale basis, with the rest sold directly to patients through its Natural Health Services (NHS) subsidiary. NHS, which operates a chain of seven medical marijuana clinics in Canada, has a patient base of some 95,000, which is served by 21 physicians. With so many footprints, Sunniva looks set to deliver the goods.

For more information, visit the company’s website at www.sunniva.com

• Recent U.S. Supreme Court ruling allowing states to legalize sports gambling aligns with FANDOM SPORTS’ emerging sports betting mobile atmosphere
• Company releases corporate update, points to multiple user acquisition strategies
• Revolutionary sports-centric social media platform able to measure, score and monetize opinionated dialogue
• Two-time Super Bowl Champion Byron Chamberlain joins FANDOM advisory group and content team
• Legal sports betting market currently estimated at more than $57 billion

FANDOM SPORTS Media Corp. (CSE: FDM) (OTC: FDMSF) (FRANKFURT: TQ42) is applauding the U.S. Supreme Court’s landmark decision that overturns a 1992 federal ban on sports betting, opening the door for states to pass laws legalizing sports gambling. FANDOM SPORTS taps into the primal, unfiltered passion of sports fans with its uncensored social media platform delivered through the FANDOM SPORTS mobile app, and, with this ruling, it no longer needs to “Pick a Fight” with the U.S. Supreme Court, according to a company press release (http://ibn.fm/lALkP).

According to a Statista survey, almost 50 percent of people 18 years and older in the U.S. confess to placing a bet on a sporting event at least once in their lives (http://ibn.fm/w6c1B). Americans wager about $150 billion on sports each year illegally, according to the American Gaming Association (http://ibn.fm/wLWQ3), while the legal sports-betting market is worth about $57.6 billion.

“FANDOM SPORTS wishes to applaud the U.S. Supreme Court for definitely getting one right,” the company states in its release. “By setting an important precedent for states to now decide whether they want to regulate and legalize sports-related gambling, fans will now have a giant obstacle to their ultimate engagement removed.”

Through the FANDOM SPORTS App, which is currently available in the Google Play store for Android devices, avid fans of all sporting venues can interact, debate, argue, talk trash and instigate virtual rumbles as they connect with other sports fans from around the world. The company’s branding slogan of “Pick a Fight. Talk Trash. Get Rewarded” is no joke for passionate sports fans who thrive on unfiltered, raw sports talk that not only feeds primal sports passions, but encourages fans to pick a side or stand alone, all while earning bragging rights and virtual currency FANCOIN™ rewards that they can use on exclusive content, real-life experiences, swag and other gear.

According to the company’s latest corporate update (http://ibn.fm/sEw47), FANDOM SPORTS closed an over-subscribed funding round of approximately $3.3 million, completed a dramatic ‘brand refresh’ and, in mid-April, released the base model version of its first Android product. FANDOM SPORTS’ current priority is the placement of its FANCOIN app economy on a blockchain technology platform that will mitigate any operational risks associated with the gamification elements and peer-to-peer micro-betting features of upcoming product releases.

FANDOM SPORTS’ distribution strategy includes both on-the-ground, guerilla street marketing campaigns and various digital user acquisition initiatives. The v2 FANDOM SPORTS App will focus content creation on matches and games with an emphasis on real-life, absolute resolutions by providing a mechanism through which clear sides can polarize the discussion and fuel the FanFight wagering with micro-bets. Users, advertisers, potential FANCOIN redemption program affiliates and industry synergy partners will all find a home in the FANDOM SPORTS trash-talking arena.

For more information, visit the company’s website at www.FANDOMSPORTSMedia.com